{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T09:38:09Z","timestamp":1770457089377,"version":"3.49.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T00:00:00Z","timestamp":1768262400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T00:00:00Z","timestamp":1768262400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"DOI":"10.1007\/s12032-026-03242-5","type":"journal-article","created":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T11:23:39Z","timestamp":1768303419000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Intracellular and exosomal miR-101-3p regulated by METTL14 confers Gefitinib sensitivity in NSCLC"],"prefix":"10.1007","volume":"43","author":[{"given":"Qinglong","family":"Kong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haoyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chundong","family":"Gu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,13]]},"reference":[{"issue":"7","key":"3242_CR1","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1038\/s41588-022-01135-7","volume":"54","author":"S Danovi","year":"2022","unstructured":"Danovi S. Lineage tracing in lung cancer. Nat Genet. 2022;54(7):921.","journal-title":"Nat Genet"},{"issue":"5","key":"3242_CR2","first-page":"409","volume":"72","author":"KD Miller","year":"2022","unstructured":"Miller KD, Nogueira L, Devasia T, Mariotto AB, Yabroff KR, Jemal A, Kramer J, Siegel RL. Cancer treatment and survivorship statistics, 2022. CA Cancer J Clin. 2022;72(5):409\u201336.","journal-title":"CA Cancer J Clin"},{"issue":"10","key":"3242_CR3","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1002\/cac2.12359","volume":"42","author":"P Chen","year":"2022","unstructured":"Chen P, Liu Y, Wen Y, Zhou C. Non-small cell lung cancer in China. Cancer Commun (Lond). 2022;42(10):937\u201370.","journal-title":"Cancer Commun (Lond)"},{"key":"3242_CR4","first-page":"100452","volume":"23","author":"Y Shi","year":"2022","unstructured":"Shi Y, Zhang X, Wu G, Xu J, He Y, Wang D, Huang C, Chen M, Yu P, Yu Y, Li W, Li Q, Hu X, Xia J, Bu L, Yin A, Zhou Y. Treatment strategy, overall survival and associated risk factors among patients with unresectable stage IIIB\/IV non-small cell lung cancer in China (2015\u20132017): A multicentre prospective study. Lancet Reg Health West Pac. 2022;23:100452.","journal-title":"Lancet Reg Health West Pac"},{"issue":"1","key":"3242_CR5","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s13045-022-01311-6","volume":"15","author":"K Shi","year":"2022","unstructured":"Shi K, Wang G, Pei J, Zhang J, Wang J, Ouyang L, Wang Y, Li W. Emerging strategies to overcome resistance to third-generation EGFR inhibitors. J Hematol Oncol. 2022;15(1):94.","journal-title":"J Hematol Oncol"},{"issue":"8","key":"3242_CR6","doi-asserted-by":"publisher","first-page":"12952","DOI":"10.1021\/acsnano.2c05355","volume":"16","author":"H Chen","year":"2022","unstructured":"Chen H, Huang C, Wu Y, Sun N, Deng C. Exosome metabolic patterns on Aptamer-Coupled polymorphic carbon for precise detection of early gastric cancer. ACS Nano. 2022;16(8):12952\u201363.","journal-title":"ACS Nano"},{"issue":"1","key":"3242_CR7","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s12943-022-01511-1","volume":"21","author":"C Chen","year":"2022","unstructured":"Chen C, Yu H, Han F, Lai X, Ye K, Lei S, Mai M, Lai M, Zhang H. Tumor-suppressive circRHOBTB3 is excreted out of cells via exosome to sustain colorectal cancer cell fitness. Mol Cancer. 2022;21(1):46.","journal-title":"Mol Cancer"},{"issue":"2","key":"3242_CR8","doi-asserted-by":"publisher","first-page":"e27","DOI":"10.1111\/ajco.13787","volume":"19","author":"S Lin","year":"2023","unstructured":"Lin S, Que Y, Que C, Li F, Deng M, Xu D. Exosome miR-3184-5p inhibits gastric cancer growth by targeting XBP1 to regulate the AKT, STAT3, and IRE1 signalling pathways. Asia Pac J Clin Oncol. 2023;19(2):e27\u201338.","journal-title":"Asia Pac J Clin Oncol"},{"key":"3242_CR9","doi-asserted-by":"crossref","unstructured":"Li X, Yang T, Shu C. The Oral Tumor Cell Exosome miR-10b Stimulates Cell Invasion and Relocation via AKT Signaling. Contrast Media Mol Imaging 2022, 2022, 3188992.","DOI":"10.1155\/2022\/3188992"},{"issue":"12","key":"3242_CR10","doi-asserted-by":"publisher","first-page":"5174","DOI":"10.21037\/tcr-21-1123","volume":"10","author":"Z Liu","year":"2021","unstructured":"Liu Z, Huang Y, Han Z, Shen Z, Yu S, Wang T, Dong Z, Kang M. Exosome-mediated miR-25\/miR-203 as a potential biomarker for esophageal squamous cell carcinoma: improving early diagnosis and revealing malignancy. Transl Cancer Res. 2021;10(12):5174\u201382.","journal-title":"Transl Cancer Res"},{"issue":"2","key":"3242_CR11","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1002\/jcb.27291","volume":"120","author":"ZY Peng","year":"2019","unstructured":"Peng ZY, Gu RH, Yan B. Downregulation of exosome-encapsulated miR-548c-5p is associated with poor prognosis in colorectal cancer. J Cell Biochem. 2019;120(2):1457\u201363.","journal-title":"J Cell Biochem"},{"issue":"2","key":"3242_CR12","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/bjc.2015.201","volume":"113","author":"T Matsumura","year":"2015","unstructured":"Matsumura T, Sugimachi K, Iinuma H, Takahashi Y, Kurashige J, Sawada G, Ueda M, Uchi R, Ueo H, Takano Y, Shinden Y, Eguchi H, Yamamoto H, Doki Y, Mori M, Ochiya T, Mimori K. Exosomal MicroRNA in serum is a novel biomarker of recurrence in human colorectal cancer. Br J Cancer. 2015;113(2):275\u201381.","journal-title":"Br J Cancer"},{"issue":"41","key":"3242_CR13","doi-asserted-by":"publisher","first-page":"4618","DOI":"10.1038\/s41388-022-02457-w","volume":"41","author":"M Li","year":"2022","unstructured":"Li M, Xu H, Qi Y, Pan Z, Li B, Gao Z, Zhao R, Xue H, Li G. Tumor-derived exosomes deliver the tumor suppressor miR-3591-3p to induce M2 macrophage polarization and promote glioma progression. Oncogene. 2022;41(41):4618\u201332.","journal-title":"Oncogene"},{"issue":"1","key":"3242_CR14","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s41065-022-00250-z","volume":"159","author":"G Zou","year":"2022","unstructured":"Zou G, Ji Q, Geng Z, Du X, Jiang L, Liu T. miR-31-5p from placental and peripheral blood exosomes is a potential biomarker to diagnose preeclampsia. Hereditas. 2022;159(1):35.","journal-title":"Hereditas"},{"key":"3242_CR15","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.bbrc.2022.12.026","volume":"641","author":"Y Jiang","year":"2023","unstructured":"Jiang Y, Qiu Q, Jing X, Song Z, Zhang Y, Wang C, Liu K, Ye F, Ji X, Luo F, Zhao R. Cancer-associated fibroblast-derived exosome miR-181b-3p promotes the occurrence and development of colorectal cancer by regulating SNX2 expression. Biochem Biophys Res Commun. 2023;641:177\u201385.","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"3242_CR16","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1186\/s12885-022-09848-y","volume":"22","author":"Q Ling","year":"2022","unstructured":"Ling Q, Wu S, Liao X, Liu C, Chen Y. Anesthetic Propofol enhances cisplatin-sensitivity of non-small cell lung cancer cells through N6-methyladenosine-dependently regulating the miR-486-5p\/RAP1-NF-kappaB axis. BMC Cancer. 2022;22(1):765.","journal-title":"BMC Cancer"},{"issue":"2","key":"3242_CR17","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1038\/s41418-022-01107-8","volume":"30","author":"Z Gao","year":"2023","unstructured":"Gao Z, Li C, Sun H, Bian Y, Cui Z, Wang N, Wang Z, Yang Y, Liu Z, He Z, Li B, Li F, Li Z, Wang L, Zhang D, Yang L, Xu Z, Li X, Xu H. N(6)-methyladenosine-modified USP13 induces pro-survival autophagy and Imatinib resistance via regulating the stabilization of autophagy-related protein 5 in Gastrointestinal stromal tumors. Cell Death Differ. 2023;30(2):544\u201359.","journal-title":"Cell Death Differ"},{"key":"3242_CR18","doi-asserted-by":"publisher","first-page":"838247","DOI":"10.3389\/fphar.2022.838247","volume":"13","author":"Y Zeng","year":"2022","unstructured":"Zeng Y, Feng Y, Fu G, Jiang J, Liu X, Pan Y, Hu C, Liu X, Wu F. Acquired concurrent EGFR T790M and driver gene resistance from EGFR-TKIs hampered osimertinib efficacy in advanced lung adenocarcinoma: case reports. Front Pharmacol. 2022;13:838247.","journal-title":"Front Pharmacol"},{"issue":"2","key":"3242_CR19","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1111\/imm.13604","volume":"168","author":"A Benito-Martin","year":"2023","unstructured":"Benito-Martin A, Nogues L, Hergueta-Redondo M, Castellano-Sanz E, Garvin E, Cioffi M, Sola-Castrillo P, Buehring W, Ximenez-Embun P, Munoz J, Matei I, Villanueva J, Peinado H. Mast cells impair melanoma cell homing and metastasis by inhibiting HMGA1 secretion. Immunology. 2023;168(2):362\u201373.","journal-title":"Immunology"},{"key":"3242_CR20","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1098\/rstb.2016.0485","volume":"373","author":"L Robado de Lope","year":"2018","unstructured":"Robado de Lope L, Alcibar OL, Amor Lopez A, Hergueta-Redondo M, Peinado H. Tumour-adipose tissue crosstalk: fuelling tumour metastasis by extracellular vesicles. Philos Trans R Soc Lond B Biol Sci. 2018;373:1737.","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"issue":"4","key":"3242_CR21","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.ccr.2014.03.007","volume":"25","author":"W Zhou","year":"2014","unstructured":"Zhou W, Fong MY, Min Y, Somlo G, Liu L, Palomares MR, Yu Y, Chow A, O\u2019Connor ST, Chin AR, Yen Y, Wang Y, Marcusson EG, Chu P, Wu J, Wu X, Li AX, Li Z, Gao H, Ren X, Boldin MP, Lin PC, Wang SE. Cancer-secreted miR-105 destroys vascular endothelial barriers to promote metastasis. Cancer Cell. 2014;25(4):501\u201315.","journal-title":"Cancer Cell"},{"issue":"8","key":"3242_CR22","doi-asserted-by":"publisher","first-page":"167454","DOI":"10.1016\/j.bbadis.2024.167454","volume":"1870","author":"MM Li","year":"2024","unstructured":"Li MM, Shi MJ, Feng CC, Yu ZY, Bai XF, Lu L. LncRNA KCNQ1OT1 promotes NLRP3 inflammasome activation in parkinson\u2019s disease by regulating pri-miR-186\/mature miR-186\/NLRP3 axis. Biochim Biophys Acta Mol Basis Dis. 2024;1870(8):167454.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"3242_CR23","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.cancergen.2024.05.001","volume":"284\u2013285","author":"J Liu","year":"2024","unstructured":"Liu J, Zhang Y, Wu J, Liu X, Li L, Zhang J. LncRNA FOXD2-AS1 promotes the growth, invasion and migration of OSCC cells by regulating the MiR-185-5p\/PLOD1\/Akt\/mTOR pathway. Cancer Genet. 2024;284\u2013285:48\u201357.","journal-title":"Cancer Genet"},{"key":"3242_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cancergen.2024.05.002","volume":"286\u2013287","author":"D Liu","year":"2024","unstructured":"Liu D, Shen M, Liu Z, Chen D, Pan Y, Zhang L, Xu X. SP1-induced circ_0017552 modulates colon cancer cell proliferation and apoptosis via up-regulation of NET1. Cancer Genet. 2024;286\u2013287:1\u201310.","journal-title":"Cancer Genet"},{"issue":"1","key":"3242_CR25","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s12943-021-01344-4","volume":"20","author":"H Liang","year":"2021","unstructured":"Liang H, Yu T, Han Y, Jiang H, Wang C, You T, Zhao X, Shan H, Yang R, Yang L, Shan H, Gu Y. Correction to: LncRNA PTAR promotes EMT and invasionmetastasis in serous ovarian cancer by competitively binding miR-101-3p to regulate ZEB1 expression. Mol Cancer. 2021;20(1):64.","journal-title":"Mol Cancer"},{"issue":"17","key":"3242_CR26","first-page":"8627","volume":"24","author":"YN Zhang","year":"2020","unstructured":"Zhang YN, Liu B, Jiang T, Li Q. Long non-coding RNA CASC15 promotes proliferation and induces apoptosis of cervical cancer cells through targeting miR-101-3p. Eur Rev Med Pharmacol Sci. 2020;24(17):8627.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"6","key":"3242_CR27","first-page":"2056","volume":"12","author":"W Sun","year":"2019","unstructured":"Sun W, Zhang Q, Wu Z, Xue N. miR-101-3p sensitizes hepatocellular carcinoma cells to oxaliplatin by inhibiting Beclin-1-mediated autophagy. Int J Clin Exp Pathol. 2019;12(6):2056\u201365.","journal-title":"Int J Clin Exp Pathol"},{"issue":"4","key":"3242_CR28","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1002\/ddr.21914","volume":"83","author":"L Sun","year":"2022","unstructured":"Sun L, Cai H, Zhou T, Xiang H, Long L. Verbascoside enhances radiosensitivity of hepatocellular carcinoma cells through regulating miR-101-3p\/Wee1 axis. Drug Dev Res. 2022;83(4):891\u20139.","journal-title":"Drug Dev Res"},{"key":"3242_CR29","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1016\/j.biopha.2017.07.005","volume":"93","author":"X Zhang","year":"2017","unstructured":"Zhang X, He X, Liu Y, Zhang H, Chen H, Guo S, Liang Y. MiR-101-3p inhibits the growth and metastasis of non-small cell lung cancer through blocking PI3K\/AKT signal pathway by targeting MALAT-1. Biomed Pharmacother. 2017;93:1065\u201373.","journal-title":"Biomed Pharmacother"},{"issue":"5","key":"3242_CR30","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1111\/1759-7714.13371","volume":"11","author":"K Li","year":"2020","unstructured":"Li K, Jiang Y, Xiang X, Gong Q, Zhou C, Zhang L, Ma Q, Zhuang L. Long non-coding RNA SNHG6 promotes the growth and invasion of non-small cell lung cancer by downregulating miR-101-3p. Thorac Cancer. 2020;11(5):1180\u201390.","journal-title":"Thorac Cancer"},{"key":"3242_CR31","doi-asserted-by":"publisher","first-page":"101908","DOI":"10.1016\/j.redox.2021.101908","volume":"42","author":"Y Luo","year":"2021","unstructured":"Luo Y, Niu G, Yi H, Li Q, Wu Z, Wang J, Yang J, Li B, Peng Y, Liang Y, Wang W, Peng Z, Shuai X, Guo Y. Nanomedicine promotes ferroptosis to inhibit tumour proliferation in vivo. Redox Biol. 2021;42:101908.","journal-title":"Redox Biol"},{"issue":"1","key":"3242_CR32","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/s12943-018-0870-5","volume":"17","author":"H Liang","year":"2018","unstructured":"Liang H, Yu T, Han Y, Jiang H, Wang C, You T, Zhao X, Shan H, Yang R, Yang L, Shan H, Gu Y. LncRNA PTAR promotes EMT and invasion-metastasis in serous ovarian cancer by competitively binding miR-101-3p to regulate ZEB1 expression. Mol Cancer. 2018;17(1):119.","journal-title":"Mol Cancer"},{"issue":"6","key":"3242_CR33","doi-asserted-by":"publisher","first-page":"BSR20181339","DOI":"10.1042\/BSR20181339","volume":"39","author":"MJ Fan","year":"2019","unstructured":"Fan MJ, Zou YH, He PJ, Zhang S, Sun XM, Li CZ. Long non-coding RNA SPRY4-IT1 promotes epithelial-mesenchymal transition of cervical cancer by regulating the miR-101-3p\/ZEB1 axis. Biosci Rep 2019;39(6)\uff1aBSR20181339.","journal-title":"Biosci Rep"},{"key":"3242_CR34","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.gene.2018.08.038","volume":"679","author":"S Yan","year":"2018","unstructured":"Yan S, Shan X, Chen K, Liu Y, Yu G, Chen Q, Zeng T, Zhu L, Dang H, Chen F, Ling J, Huang A, Tang H. LINC00052\/miR-101-3p axis inhibits cell proliferation and metastasis by targeting SOX9 in hepatocellular carcinoma. Gene. 2018;679:138\u201349.","journal-title":"Gene"},{"issue":"1","key":"3242_CR35","doi-asserted-by":"publisher","first-page":"7424","DOI":"10.1038\/s41467-023-43307-x","volume":"14","author":"X Lin","year":"2023","unstructured":"Lin X, Chai G, Wu Y, Li J, Chen F, Liu J, Luo G, Tauler J, Du J, Lin S, He C, Wang H. Retraction Note: RNA m(6)A methylation regulates the epithelial mesenchymal transition of cancer cells and translation of snail. Nat Commun. 2023;14(1):7424.","journal-title":"Nat Commun"},{"key":"3242_CR36","doi-asserted-by":"crossref","unstructured":"Yan C, Xiong J, Zhou Z, Li Q, Gao C, Zhang M, Yu L, Li J, Hu MM, Zhang CS, Cai C, Zhang H, Zhang J. A cleaved METTL3 potentiates the METTL3-WTAP interaction and breast cancer progression. Elife 2023, 12.","DOI":"10.7554\/eLife.87283"},{"issue":"1","key":"3242_CR37","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s13046-022-02581-1","volume":"42","author":"Y Xu","year":"2023","unstructured":"Xu Y, Song M, Hong Z, Chen W, Zhang Q, Zhou J, Yang C, He Z, Yu J, Peng X, Zhu Q, Li S, Ji K, Liu M, Zuo Q. The N6-methyladenosine METTL3 regulates tumorigenesis and Glycolysis by mediating m6A methylation of the tumor suppressor LATS1 in breast cancer. J Exp Clin Cancer Res. 2023;42(1):10.","journal-title":"J Exp Clin Cancer Res"},{"key":"3242_CR38","doi-asserted-by":"crossref","unstructured":"Ge Y, Zhang Y, Yang S, Liu T, Zhang T, Feng Y, Wang C, Liang G. The Comprehensive Analysis of N6-Methyadenosine Writer METTL3 and METTL14 in Gastric Cancer. J Oncol 2023, 2023, 9822995.","DOI":"10.1155\/2023\/9822995"},{"issue":"1","key":"3242_CR39","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1186\/s12943-020-01249-8","volume":"19","author":"M Wang","year":"2020","unstructured":"Wang M, Liu J, Zhao Y, He R, Xu X, Guo X, Li X, Xu S, Miao J, Guo J, Zhang H, Gong J, Zhu F, Tian R, Shi C, Peng F, Feng Y, Yu S, Xie Y, Jiang J, Li M, Wei W, He C, Qin R. Upregulation of METTL14 mediates the elevation of PERP mRNA N(6) adenosine methylation promoting the growth and metastasis of pancreatic cancer. Mol Cancer. 2020;19(1):130.","journal-title":"Mol Cancer"},{"issue":"1","key":"3242_CR40","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s12943-020-1146-4","volume":"19","author":"X Yang","year":"2020","unstructured":"Yang X, Zhang S, He C, Xue P, Zhang L, He Z, Zang L, Feng B, Sun J, Zheng M. METTL14 suppresses proliferation and metastasis of colorectal cancer by down-regulating oncogenic long non-coding RNA XIST. Mol Cancer. 2020;19(1):46.","journal-title":"Mol Cancer"},{"key":"3242_CR41","doi-asserted-by":"publisher","first-page":"107402","DOI":"10.1016\/j.compbiomed.2023.107402","volume":"165","author":"J Huang","year":"2023","unstructured":"Huang J, Zhang J, Zhang F, Lu S, Guo S, Shi R, Zhai Y, Gao Y, Tao X, Jin Z, You L, Wu J. Identification of a disulfidptosis-related genes signature for prognostic implication in lung adenocarcinoma. Comput Biol Med. 2023;165:107402.","journal-title":"Comput Biol Med"},{"issue":"5","key":"3242_CR42","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1002\/cac2.70005","volume":"45","author":"D Shan","year":"2025","unstructured":"Shan D, Song J, Ren Y, Zhang Y, Ba Y, Luo P, Cheng Q, Xu H, Weng S, Zuo A, Liu S, Han X, Deng J, Liu Z. Copper in cancer: friend or foe? Metabolism, dysregulation, and therapeutic opportunities. Cancer Commun (Lond). 2025;45(5):577\u2013607.","journal-title":"Cancer Commun (Lond)"},{"issue":"3\u20134","key":"3242_CR43","doi-asserted-by":"publisher","first-page":"CBM240119","DOI":"10.3233\/CBM-240119","volume":"41","author":"AM Rasteh","year":"2024","unstructured":"Rasteh AM, Liu H, Wang P. Pan-cancer genetic profiles of mitotic DNA integrity checkpoint protein kinases. Cancer Biomark. 2024;41(3\u20134):CBM240119.","journal-title":"Cancer Biomark"},{"issue":"8","key":"3242_CR44","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1158\/1535-7163.MCT-24-1194","volume":"24","author":"J Ma","year":"2025","unstructured":"Ma J, Liu W, Li J, Kim D, Kim S, Levy A, Cai Z, Bunker KD, Recio-Boiles A, Segar JM, Sen S, Doroshow DB, Jandial D, Rutgard M, Harismendy O, Grant SK, Samatar AA, Fischer KM, Lackner MR. Azenosertib is a potent and selective WEE1 kinase inhibitor with broad antitumor activity across a range of solid tumors. Mol Cancer Ther. 2025;24(8):1171\u201385.","journal-title":"Mol Cancer Ther"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-026-03242-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12032-026-03242-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-026-03242-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T16:04:46Z","timestamp":1770393886000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12032-026-03242-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,13]]},"references-count":44,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,2]]}},"alternative-id":["3242"],"URL":"https:\/\/doi.org\/10.1007\/s12032-026-03242-5","relation":{},"ISSN":["1559-131X"],"issn-type":[{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,13]]},"assertion":[{"value":"27 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"117"}}